Endocrinology, Vol 120, 1361-1369, Copyright © 1987 by Endocrine Society

ARTICLES

Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy

PM Plotsky and PE Sawchenko

Changes in immunostaining, median eminence content, and secretion into the hypophysial-portal circulation of immunoreactive CRF (irCRF), arginine vasopressin (irAVP), and oxytocin (irOT) were directly evaluated after pharmacological adrenalectomy (PHADX). Mean circulating levels of ACTH rose from 270 +/- 57 (+/- SE) to 1560 +/- 283 pg/ml after 72 h of treatment with metyrapone and aminoglutethimide. Initially, hypophysial-portal plasma irCRF levels decreased to 52.6% (12 h) and 21.7% (24 h) of control levels (230 +/- 41 pg/ml). Accompanying changes in the patterns of CRF immunostaining in the paraventricular nuclei (PVN) or in median eminence irCRF content at 24 h did not parallel alterations in portal plasma irCRF levels at this time. By 72 h posttreatment, portal irCRF levels were elevated 2.2- fold, while the number of detectable CRF-positive perikarya in the PVN increased 3.0-fold. The mean hypophysial-portal plasma irAVP concentration was unchanged from the control value (1312 +/- 287 pg/ml) at 12 h, but was only 34.9% of the control value at 24 h. Inverse changes in median eminence irAVP content were noted at these times, whereas the number of AVP-immunostained cells exhibited a tendency toward an increase at 24 h, in parallel with significantly increased content. By 72 h post-PHADX, portal irAVP, median eminence irAVP content, irAVP immunostaining intensity, and AVP-immunopositive cell number were elevated. Approximately 64% of CRF-positive perikarya in the parvocellular PVN costained for AVP at this time, whereas no colocalization was evident in untreated rats. These changes were prevented by corticosterone replacement. irOT staining intensity, irOT- positive cell number, median eminence irOT content, and portal plasma irOT concentration remained stable at all times examined. We conclude that: removal of adrenal steroids by PHADX results in a sequence of changes in CRF and AVP within the PVN (as determined by immunocytochemistry) and the median eminence (as determined by peptide content) similar to those observed after surgical adrenalectomy; after steroid removal the secretion of both irCRF and irAVP changes in a biphasic manner characterized by reduced secretion at 24 h and greatly enhanced secretion at 72 h; neither immunostaining nor median eminence content alone proved to be a reliable index or secretory activity during the initial phases of steroid blockade; and the hypophysiotropic OT system of normal male rats appears to be insensitive to adrenal steroid influences.

This article has been cited by other articles:

				S. Subburaju and G. Aguilera Vasopressin Mediates Mitogenic Responses to Adrenalectomy in the Rat Anterior Pituitary Endocrinology, July 1, 2007; 148(7): 3102 - 3110. [Abstract] [Full Text] [PDF]

				G. van Dijk, K. de Vries, C. Nyakas, B. Buwalda, T. Adage, F. Kuipers, M. J. H. Kas, R. A. H. Adan, C. W. Wilkinson, T. E. Thiele, et al. Reduced Anorexigenic Efficacy of Leptin, But Not of the Melanocortin Receptor Agonist Melanotan-II, Predicts Diet-Induced Obesity in Rats Endocrinology, December 1, 2005; 146(12): 5247 - 5256. [Abstract] [Full Text] [PDF]

				S. Ma, M. J. Shipston, D. Morilak, and J. A. Russell Reduced Hypothalamic Vasopressin Secretion Underlies Attenuated Adrenocorticotropin Stress Responses in Pregnant Rats Endocrinology, March 1, 2005; 146(3): 1626 - 1637. [Abstract] [Full Text] [PDF]

				D. M. Keenan and J. D. Veldhuis Cortisol feedback state governs adrenocorticotropin secretory-burst shape, frequency, and mass in a dual-waveform construct: time of day-dependent regulation Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R950 - R961. [Abstract] [Full Text] [PDF]

				K. Kageyama, C. Li, and W. W. Vale Corticotropin-Releasing Factor Receptor Type 2 Messenger Ribonucleic Acid in Rat Pituitary: Localization and Regulation by Immune Challenge, Restraint Stress, and Glucocorticoids Endocrinology, April 1, 2003; 144(4): 1524 - 1532. [Abstract] [Full Text] [PDF]

				K. D. Laugero, F. Gomez, S. Manalo, and M. F. Dallman Corticosterone Infused Intracerebroventricularly Inhibits Energy Storage and Stimulates the Hypothalamo-Pituitary Axis in Adrenalectomized Rats Drinking Sucrose Endocrinology, December 1, 2002; 143(12): 4552 - 4562. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, A. Iranmanesh, D. Naftolowitz, N. Tatham, F. Cassidy, and B. J. Carroll Corticotropin Secretory Dynamics in Humans under Low Glucocorticoid Feedback J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5554 - 5563. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, M. Straume, A. Iranmanesh, T. Mulligan, C. Jaffe, A. Barkan, M. L. Johnson, and S. Pincus Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R721 - R729. [Abstract] [Full Text] [PDF]

				M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]

				K.-H. Jeong, L. Jacobson, K. Pacak, E. P. Widmaier, D. S. Goldstein, and J. A. Majzoub Impaired Basal and Restraint-Induced Epinephrine Secretion in Corticotropin-Releasing Hormone- Deficient Mice Endocrinology, March 1, 2000; 141(3): 1142 - 1150. [Abstract] [Full Text] [PDF]

				N. B. Hastings, M. Orchinik, M. V. Aubourg, and B. S. McEwen Pharmacological Characterization of Central and Peripheral Type I and Type II Adrenal Steroid Receptors in the Prairie Vole, a Glucocorticoid-Resistant Rodent Endocrinology, October 1, 1999; 140(10): 4459 - 4469. [Abstract] [Full Text]

				D. Engler, E. Redei, and I. Kola The Corticotropin-Release Inhibitory Factor Hypothesis: A Review of the Evidence for the Existence of Inhibitory as Well as Stimulatory Hypophysiotropic Regulation of Adrenocorticotropin Secretion and Biosynthesis Endocr. Rev., August 1, 1999; 20(4): 460 - 500. [Abstract] [Full Text] [PDF]

				Z. A. Erkut, C. Pool, and D. F. Swaab Glucocorticoids Suppress Corticotropin-Releasing Hormone and Vasopressin Expression in Human Hypothalamic Neurons J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2066 - 2073. [Abstract] [Full Text]

				D. A. Giussani, J. A. Winter, S. L. Jenkins, J. D. Tame, L. M. Abrams, X.-Y. Ding, and P. W. Nathanielsz Changes in Fetal Plasma Corticotropin-Releasing Hormone during Androstenedione-Induced Labor in the Rhesus Monkey: Lack of an Effect on the Fetal Hypothalamo-Pituitary-Adrenal Axis Endocrinology, June 1, 1998; 139(6): 2803 - 2810. [Abstract] [Full Text] [PDF]

				J. A. Yanovski, L. K. Nieman, J. L. Doppman, G. P. Chrousos, R. L. Wilder, P. W. Gold, and K. T. Kalogeras Plasma Levels of Corticotropin-Releasing Hormone in the Inferior Petrosal Sinuses of Healthy Volunteers, Patients with Cushing's Syndrome, and Patients with Pseudo-Cushing States J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1485 - 1488. [Abstract] [Full Text]

				F. Gomez, E. R. De Kloet, and A. Armario Glucocorticoid negative feedback on the HPA axis in five inbred rat strains Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R420 - R427. [Abstract] [Full Text] [PDF]

				J. Raber, R. D. O'Shea, F. E. Bloom, and I. L. Campbell Modulation of Hypothalamic-Pituitary-Adrenal Function by Transgenic Expression of Interleukin-6 in the CNS of Mice J. Neurosci., December 15, 1997; 17(24): 9473 - 9480. [Abstract] [Full Text] [PDF]

				C. Rabadan-Diehl, G. Makara, A. Kiss, S. Lolait, D. Zelena, T. Ochedalski, and G. Aguilera Regulation of Pituitary V1b Vasopressin Receptor Messenger Ribonucleic Acid by Adrenalectomy and Glucocorticoid Administration Endocrinology, December 1, 1997; 138(12): 5189 - 5194. [Abstract] [Full Text] [PDF]

				P. J. Larsen, M. Tang-Christensen, and D. S. Jessop Central Administration of Glucagon-Like Peptide-1 Activates Hypothalamic Neuroendocrine Neurons in the Rat Endocrinology, October 1, 1997; 138(10): 4445 - 4455. [Abstract] [Full Text] [PDF]

				D. Liu, J. Diorio, B. Tannenbaum, C. Caldji, D. Francis, A. Freedman, S. Sharma, D. Pearson, P. M. Plotsky, and M. J. Meaney Maternal Care, Hippocampal Glucocorticoid Receptors, and Hypothalamic-Pituitary-Adrenal Responses to Stress Science, September 12, 1997; 277(5332): 1659 - 1662. [Abstract] [Full Text]

				D. A. Van Vugt, J. Piercy, A. E. Farley, R. L. Reid, and S. Rivest Luteinizing Hormone Secretion and Corticotropin-Releasing Factor Gene Expression in the Paraventricular Nucleus of Rhesus Monkeys Following Cortisol Synthesis Inhibition Endocrinology, June 1, 1997; 138(6): 2249 - 2258. [Abstract] [Full Text] [PDF]

				Y. Shaham, D. Funk, S. Erb, T. J. Brown, C.-D. Walker, and J. Stewart Corticotropin-Releasing Factor, But Not Corticosterone, Is Involved in Stress-Induced Relapse to Heroin-Seeking in Rats J. Neurosci., April 1, 1997; 17(7): 2605 - 2614. [Abstract] [Full Text] [PDF]

				L. A. Pavcovich and R. J. Valentino Regulation of a Putative Neurotransmitter Effect of Corticotropin-Releasing Factor: Effects of Adrenalectomy J. Neurosci., January 1, 1997; 17(1): 401 - 408. [Abstract] [Full Text] [PDF]

				K Karalis, H Sano, J Redwine, S Listwak, R. Wilder, and G. Chrousos Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo Science, October 18, 1991; 254(5030): 421 - 423. [Abstract] [PDF]